# Cancer gene therapy

Source: https://onco.cc/journals/cancer-gene-therapy/  
OnCo record `cancer-gene-therapy` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer Gene Therapy covers gene and cell therapies for cancer, from CAR-T cells to oncolytic viruses and gene editing. Read by translational researchers and clinicians developing these treatments.

## Summary

Cancer Gene Therapy, published by Springer Nature on nature.com, describes itself as the essential gene and cellular therapy resource for cancer researchers and clinicians. It publishes research articles, reviews and analysis, brief communications and news and comment on gene therapy, cellular therapy including CAR-T cells, cancer biology, drug discovery, genetics, immunology, molecular biology and biomarkers. It is a hybrid journal: subscription content with an open access option and open access funding guidance for authors. The journal began in 1994 and has appeared twelve times a year since 2000. Its editorial checks include cover letters on institutional letterhead and author contribution statements. Indexed in MEDLINE.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Cancer Gene Ther; Cancer Gene Therapy
- Publisher: Springer Nature
- Scope: cancer gene and cell therapy
- Access: hybrid

## Sources

- Homepage: https://www.nature.com/cgt/
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/9432230

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [Oncolytic viruses](https://onco.cc/technologies/oncolytic-virus/)

---
JSON: https://onco.cc/api/v1/entities/cancer-gene-therapy.json